We are live on ! Find out more
ICU icon

SeaStar Medical
ICU

38 hedge funds and large institutions have $91.8M invested in SeaStar Medical in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

26% more capital invested

Capital invested by funds: $72.7M → $91.8M (+$19.1M)

15% more funds holding

Funds holding: 33 → 38 (+5)

0.03% more ownership

Funds ownership: 0.28% → 0.31% (+0.03%)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.57M
2
SCM
Saba Capital Management
New York
+$2.04M
3
RCM
Rivernorth Capital Management
Florida
+$1.49M
4
MSU
Mizuho Securities USA
New York
+$1.03M
5
KKRC
Kohlberg Kravis Roberts & Co
New York
+$721K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$2.97M
2
KIM
Karpus Investment Management
New York
-$54.5K
3
PCM
Prelude Capital Management
New York
-$27.3K
4
BFM
Boothbay Fund Management
New York
-$24.8K
5
UBS Group
UBS Group
Switzerland
-$19.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$14.2M -$54.5K -22 -0.4%
KKRC
2
Kohlberg Kravis Roberts & Co
New York
$11.9M +$721K +291 +262%
SCM
3
Saba Capital Management
New York
$9.77M +$2.04M +825 +27%
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$7.53M – – –
WRBC
5
W.R. Berkley Corp
Connecticut
$4.58M +$691K +279 +18%
CH
6
CVI Holdings
Delaware
$4.02M – – –
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$4.02M – – –
BFM
8
Boothbay Fund Management
New York
$3.61M -$24.8K -10 -0.7%
ASM
9
ATW SPAC Management
New York
$3.52M – – –
MSU
10
Mizuho Securities USA
New York
$3.19M +$1.03M +417 +48%
HSBC Holdings
11
HSBC Holdings
United Kingdom
$3.1M – – –
PC
12
Periscope Capital
Ontario, Canada
$3.01M – – –
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$2.6M +$2.57M +1,038 New
RCM
14
Radcliffe Capital Management
Pennsylvania
$2.51M – – –
Goldman Sachs
15
Goldman Sachs
New York
$2.12M – – –
LP
16
LMR Partners
United Kingdom
$1.76M – – –
RCM
17
Rivernorth Capital Management
Florida
$1.51M +$1.49M +600 New
Millennium Management
18
Millennium Management
New York
$1.15M +$223K +90 +25%
WAM
19
Wolverine Asset Management
Illinois
$965K +$81.8K +33 +9%
Citadel Advisors
20
Citadel Advisors
Florida
$674K +$27.3K +11 +4%
GCIA
21
Gabelli & Co Investment Advisers
New York
$619K – – –
GF
22
Gabelli Funds
New York
$613K – – –
PNC Financial Services Group
23
PNC Financial Services Group
Pennsylvania
$564K – – –
AA
24
AQR Arbitrage
Connecticut
$564K +$24.8K +10 +5%
CM
25
Crestline Management
Texas
$512K – – –
1
2

ICU Hedge Fund Activity: Q3 2021 in Review

38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2021, worth a combined $91.8M — up 26% from $72.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ICU positions and 2 closed out — a net gain of 5 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $2.57M. The largest seller was Mangrove Partners, exiting entirely with an estimated $2.97M sold.

  • 38 institutional investors held SeaStar Medical (ICU) as of Q3 2021, up from 33 in Q2 2021.
  • Funds reported $91.8M of SeaStar Medical stock for Q3 2021, up 26% quarter-over-quarter.
  • 7 funds opened new SeaStar Medical positions in Q3 2021 and 2 closed out, a net change of +5 holders.
  • The largest SeaStar Medical buyer in Q3 2021 was D.E. Shaw & Co, an estimated $2.57M added.
  • The largest SeaStar Medical seller in Q3 2021 was Mangrove Partners, an estimated $2.97M sold.

Based on aggregated 13F filings for Q3 2021.